Soluble ICAM-1 in Hodgkin's Disease: A Promising Independent Predicitive Marker for Survial

Adhesion receptors of the immune system

1990 • 6,585 citations

Report of the Committee on Hodgkin's Disease Staging Classification.

1971 • 4,212 citations

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

1986 • 2,490 citations

Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)

1987 • 1,712 citations

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

1986 • 1,439 citations

Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.

1989 • 1,115 citations

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells.

1988 • 988 citations

A form of circulating ICAM-1 in human serum.

1991 • 700 citations

Structure and Function of Leukocyte Integrins

1990 • 620 citations

ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells

1988 • 580 citations

Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies.

1988 • 569 citations

Leukemia Following Hodgkin's Disease

1990 • 502 citations

Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders

1991 • 387 citations

The function of human intercellular adhesion molecule‐1 (ICAM‐1) in the generation of an immune response

1988 • 351 citations

Regulatory mechanisms in leukocyte adhesion: flexible receptors for sophisticated travelers

1992 • 260 citations

Hodgkin's Disease

1992 • 220 citations

Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.

1991 • 173 citations

Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction.

1993 • 143 citations

Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage

1990 • 103 citations

Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.

1991 • 99 citations

DETECTION OF CIRCULATING INTERCELLULAR ADHESION MOLECULE-1 AFTER LIVER TRANSPLANTATION-EVIDENCE OF LOCAL RELEASE WITHIN THE LIVER DURING GRAFT REJECTION

1993 • 92 citations

Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease

1991 • 86 citations

Production of tumor necrosis factor-alpha and lymphotoxin by cells of Hodgkin's neoplastic cell lines HDLM-1 and KM-H2.

1989 • 68 citations

Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor.

1990 • 68 citations

Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1.

1993 • 64 citations

Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers [see comments]

1994 • 54 citations

Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T‐cell leukemia and infectious mononucleosis

1990 • 53 citations

Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

1990 • 49 citations

ICAM‐1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's disease

1993 • 40 citations

Efficient killing of chronic B-lymphocytic leukemia cells by superantigen-directed T cells

1993 • 39 citations

Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome

1993 • 36 citations

Serum intercellular adhesion molecule-1 in childhood malignancy

1993 • 34 citations

Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus

1993 • 33 citations

Serum Thymidine Kinase as a Prognostic Marker in Hodgkin's Disease

1985 • 31 citations

in situ expression of the IL‐I‐α and tnf‐α genes by reed‐sternberg cells in Hodgkin's disease

1992 • 29 citations

Immunohistochemical characteristics of Hodgkin and Reed‐Sternberg cells in relation to age and clinical outcome

1993 • 28 citations

Hodgkin's cells express a novel pattern of adhesion molecules

1992 • 28 citations

Prognostic value of serum lactic dehydrogenase level in Hodgkin's disease.

1982 • 26 citations

Influence of clinical trials on current treatment strategy for Hodgkin's disease

1990 • 19 citations

Cell Surface Expression of ICAM-1 (CD54) and LFA-3 (CD58), Two Adhesion Molecules, Is Up-Regulated on Bone Marrow Leukemic Blasts After In Vivo Administration of High-Dose Recombinant Interleukin-2

1991 • 18 citations

Serum interleukin-2 receptor levels in Hodgkin disease and other solid tumors of childhood.

1993 • 17 citations

[Elevated serum levels of ICAM-1 in Wegener's granulomatosis].

1992 • 11 citations

Workshop I: Review on prognostic factors

1992 • 10 citations

Increasing Interdependency of Prognosis- and Therapy-Related Factors in Hodgkin’s Disease

1989 • 9 citations

Classical staging of Hodgkin's disease is inappropriate for selecting patients for clinical trials of intensive therapy: the case for the objective use of prognostic factor information in addition to classical staging.

1993 • 9 citations